The report “Global Barrett Esophagus Market, By Treatment (Medications (Proton Pump Inhibitors, Antacids, H2 Blockers, Promotility Agents, and Others) and Surgical Treatment (Radiofrequency Ablation, Photodynamic Therapy, Endoscopic Spray Cryotherapy, Endoscopic Mucosal Resection, and Surgery)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Over The Counter, and Others), and Region – Global Forecast to 2029″ Global barrett esophagus market is projected to grow from US$ XX billion in 2019 to US$ XX billion by 2029. Global barrett esophagus market is driven by growing incidence correlated with esophageal diseases across the global. In addition, rising number of patients suffering from gastro esophagus reflux disease (GERD) increases the risk of barrett’s esophagus which propels growth of the global market. Increasing consumption of alcohol causes GERD among individuals and growing lifestyle changes causing obesity which indirectly leads to barrett’s esophagus are projected to contribute growth of the global barrett esophagus market.
Request Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/1448
- On August 2019, AstraZeneca has announced that its cancer drug called ‘Lynparza’ has been successful in helping patients with metastatic prostate cancer and certain genetic mutations with a aim to live longer without disease worsening.
- In June 2019, Takeda Pharmaceutical Company Limited has announced its additional five partners to Global CSR Program, which contributes for long-term health of people by preventing diseases and capacity building in developing and emerging countries.
- On July 2019, Pfizer Inc. has announced the successful completion of its acquisition with Array BioPharma Inc. The acquisition includes development, discovery, and commercialization of targeted small molecule medicines to treat cancer and other diseases.
Key Market Insights from the report:
The global barrett esophagus market accounted for US$ XX billion in 2019 and is projected to register a moderate CAGR of XX% over the forecast period. The market report has been segmented on the basis of treatment, distribution channel, and region.
- By treatment, the global barrett esophagus market is segmented into medications and surgical treatment. The medications treatment segment is further divided into proton pump inhibitors, antacids, h2 blockers, promotility agents, and others. The Surgical treatment segment is further divided into radiofrequency ablation, photodynamic therapy, endoscopic spray cryotherapy, endoscopic mucosal resection, and surgery.
- By distribution channel, the global barrett esophagus market is categorized into hospital pharmacies, retail pharmacies, over the counter, and others. The hospital pharmacies distribution channel segment is accounted to hold highest global market share over the forecast period.
- By region, North America is accounted to hold highest global market share, owing to the increasing incidence and prevalence of the disease. In addition, focus of various organizations to create well-developed healthcare infrastructure and creating awareness among people. Europe is accounted to be the second dominant region in the global barrett esophagus market over the forecast period. This is attributed due to sluggish economic growth in this region. Asia Pacific is expected to hold a significant position for growth of the global market over the forecast period, owing to significant contribution from emerging countries such as India and China.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “ Global Barrett esophagus Market”, By Treatment (Medications (Proton Pump Inhibitors, Antacids, H2 Blockers, Promotility Agents, and Others) and Surgical Treatment (Radiofrequency Ablation, Photodynamic Therapy, Endoscopic Spray Cryotherapy, Endoscopic Mucosal Resection, and Surgery)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Over The Counter, and Others), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2029
To know the upcoming trends and insights prevalent in this market, click the link below:
The prominent player operating in the global barrett esophagus market includes Addex Therapeutics Ltd., AstraZeneca, Plc., Rottapharm (Meda AB), Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Torax Medical, Inc., Mederi Therapeutics, Inc., Aros Pharma AS, and Torax Medical, Inc.
About Prophecy Market Insights
Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
Prophecy Market Insights